These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9871584)

  • 21. Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists.
    Baraldi PG; Cacciari B; Spalluto G; Bergonzoni M; Dionisotti S; Ongini E; Varani K; Borea PA
    J Med Chem; 1998 Jun; 41(12):2126-33. PubMed ID: 9622554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel 3-aralkyl-7-(amino-substituted)-1,2,3-triazolo[4,5-d]pyrimidines with high affinity toward A1 adenosine receptors.
    Betti L; Biagi G; Giannaccini G; Giorgi I; Livi O; Lucacchini A; Manera C; Scartoni V
    J Med Chem; 1998 Feb; 41(5):668-73. PubMed ID: 9513594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP; Curtis AR; Kendall DA; Hill SJ
    Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
    Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E
    J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and structure-activity relationship of pyrazolo[3,4-d]pyrimidines: potent and selective adenosine A1 receptor antagonists.
    Poulsen SA; Quinn RJ
    J Med Chem; 1996 Oct; 39(21):4156-61. PubMed ID: 8863792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-pressure synthesis of enantiomerically pure C-6 substituted pyrazol.
    Poulsen SA; Young DJ; Quinn RJ
    Bioorg Med Chem Lett; 2001 Jan; 11(2):191-3. PubMed ID: 11206456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
    Zhou QY; Li C; Olah ME; Johnson RA; Stiles GL; Civelli O
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7432-6. PubMed ID: 1323836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptive changes in adenosine receptors following long-term treatment with the adenosine receptor agonist R-phenylisopropyl adenosine.
    Fernandez M; Svenningsson P; Fredholm BB
    Life Sci; 1996; 58(9):769-76. PubMed ID: 8632724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-related characterization of atrial adenosine A1 receptor activation: direct effects on chronotropic and inotropic function in the Fischer 344 rat.
    Montamat SC; Olson RD; Mudumbi RV; Vestal RE
    J Gerontol A Biol Sci Med Sci; 1996 Jul; 51(4):B239-46. PubMed ID: 8680987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of A1 and A2a adenosine receptor binding in aged striatum, hippocampus and cortex of the rat.
    Cunha RA; Constantino MC; Sebastião AM; Ribeiro JA
    Neuroreport; 1995 Jul; 6(11):1583-8. PubMed ID: 7579154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of novel pyrido[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives: potent and selective adenosine A3 receptor antagonists.
    Banda V; Chandrasekaran B; Köse M; Vielmuth C; Müller CE; Chavva K; Gautham SK; Pillalamarri S; Mylavaram R; Akkinepally R; Pamulaparthy S; Banda N
    Arch Pharm (Weinheim); 2013 Oct; 346(10):699-707. PubMed ID: 23996524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amino-substituted 1,8-naphthyridines and pyrido[2,3-d]pyrimidines: new compounds with affinity for A1- and A2-adenosine receptors.
    Müller CE; Grahner B; Heber D
    Pharmazie; 1994 Dec; 49(12):878-80. PubMed ID: 7838877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
    Klotz KN; Hessling J; Hegler J; Owman C; Kull B; Fredholm BB; Lohse MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):1-9. PubMed ID: 9459566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contraction of the rat isolated spleen mediated by adenosine A1 receptor activation.
    Fozard JR; Milavec-Krizman M
    Br J Pharmacol; 1993 Aug; 109(4):1059-63. PubMed ID: 8401917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of chronic administration of caffeine on adenosine A1 and A2 receptors in rat brain.
    Hawkins M; Dugich MM; Porter NM; Urbancic M; Radulovacki M
    Brain Res Bull; 1988 Sep; 21(3):479-82. PubMed ID: 3214753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the prejunctional adenosine receptors in the rat anococcygeus muscle.
    Coates J; Green MA; Sheehan MJ; Strong P
    J Pharm Pharmacol; 1994 Nov; 46(11):906-10. PubMed ID: 7897597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic exposure to adenosine receptor agonists and antagonists reciprocally regulates the A1 adenosine receptor-adenylyl cyclase system in cerebellar granule cells.
    Hettinger-Smith BD; Leid M; Murray TF
    J Neurochem; 1996 Nov; 67(5):1921-30. PubMed ID: 8863496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-dependent decrease in adenosine A1 receptor binding sites in the rat brain. Effect of cis unsaturated free fatty acids.
    Cunha RA; Constantino MD; Fonseca E; Ribeiro JA
    Eur J Biochem; 2001 May; 268(10):2939-47. PubMed ID: 11358511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenosine A1 agonists and the Ca2+ channel agonist bay K 8644 produce a synergistic stimulation of the GTPase activity of Go in rat frontal cortical membranes.
    Sweeney MI; Dolphin AC
    J Neurochem; 1995 May; 64(5):2034-42. PubMed ID: 7536803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.